Updated 21 October 2026.
Clinical AI competition is often presented as a contest between models. Yet a product can answer impressively and still struggle if using it means leaving the clinical workflow, repeating information or copying results between systems. Conversely, a well-placed function can become part of routine work because it appears at the moment it is needed.
Tandem Health's integration directory makes connectivity central to its proposition. Its September fundraising announcement reported connections with more than 130 medical record systems. That is a company-reported breadth measure, not an independent assessment of how deeply every connection works or how frequently clinicians use it.
Distribution begins before a clinician compares answers
Imagine two hypothetical assistants with similar task performance. One requires a new account, a separate window and repeated manual context entry. The other appears inside an established workflow with the correct permissions and a familiar support route. The second may be easier to adopt even before the organisation considers subtle differences in output quality.
This is why distribution deserves attention. Access, familiarity and implementation support can affect which products clinicians actually encounter. A technically capable newcomer may be competing not only against a rival model but also against existing organisational habits, procurement relationships and the practical cost of changing those habits.
None of this establishes that integration should outweigh accuracy or safety. It explains why a comparison based only on an isolated answer misses an important part of the buying decision. The relevant unit is the completed clinical task, including the work required to reach and verify the answer.
The Accurx partnership illustrates access through an established channel
Tandem's April 2025 announcement with Accurx described Accurx Scribe powered by Tandem and an opportunity to make the service available through a platform already used in the NHS. The strategic significance is the route to clinicians through an established communication environment.
Availability is not the same as adoption. The size of a partner's user base does not establish how many clinicians activate a new function, continue using it or receive the same feature set. Headlines about potential reach should therefore be kept separate from evidence of sustained use.
Partnership distribution also introduces dependence. The experience may rely on the partner's interface, release schedule, commercial arrangements and support processes. Buyers should know which organisation handles clinical questions, technical incidents and contract changes. A seamless demonstration does not eliminate the need for a clear division of responsibilities.
Aurora teleQ shows why the point of capture matters
On 23 September 2026, Tandem announced an integration with Aurora teleQ, initially available to Swedish healthcare providers using that communication platform. It connects patient calls or other contact with Tandem's note-generation workflow. The announcement should not be presented as an NHS deployment or universal availability in every market.
The interesting design principle is proximity to the event being documented. If documentation begins within the existing communication flow, staff may have less reason to recreate context elsewhere. Whether that produces a net benefit depends on capture quality, review effort and the destination of the approved output.
A useful evaluation would follow a complete call from initiation through review and filing. It would include interruptions, poor audio, mistaken patient selection and failed transfers. Testing only a clean example of generated prose would miss much of the value and risk of the integration.
An integration can mean several different things
A connection might launch another application, pass limited context, export text or exchange structured information through an authenticated interface. These are not equivalent capabilities. They create different opportunities for reducing work and different failure modes.
A procurement team should therefore ask what moves, in which direction, under whose identity and with what confirmation. Does the system read information, write information or both? Does it transfer a complete note, selected fields or suggested codes? What happens when the destination is unavailable or the user changes patient records midway through the task?
These questions turn an integration claim into an assessable workflow. They also make comparisons fairer. A supplier with a smaller catalogue of deep, dependable connections could be more suitable for a particular organisation than one with a larger list of lighter-touch options.
Connectivity creates maintenance obligations as well as a moat
Every external dependency can change. Interfaces evolve, permissions are revised and clinical organisations configure the same record system differently. The value of a connection depends partly on the supplier's capacity to maintain it and diagnose problems when responsibility is shared.
This is where scale might become an advantage. Reusable engineering, deployment experience and support processes can make subsequent installations more efficient. The opposite is also possible: expansion can accumulate bespoke work that is difficult to maintain. Public integration counts alone do not reveal which pattern is occurring.
Buyers should ask for change-notification arrangements, testing responsibilities and practical service commitments. They should also understand what remains usable during an integration failure. A safe fallback may be less convenient than the normal workflow, but it should be defined before the organisation depends on the connection.
Switching costs should be visible before purchase
Integration can produce legitimate value and still make switching harder. Templates, configuration, permissions, training and clinical safety documentation may all become tied to a particular deployment. The cost of leaving is therefore broader than exporting a document.
A sensible agreement should address data portability, retention, access after termination and responsibility for dismantling connections. Buyers should distinguish the clinical record, supplier-generated artefacts and configuration that may be needed elsewhere. They should not discover the practical limits of portability only when the contract ends.
Open interfaces can help, but the word "open" is not enough. Access terms, documentation, testing support and the availability of useful export formats determine whether another service can genuinely replace or complement the original one.
What this means for independent clinical reference
This article is published by iatroX, which offers clinical reference and learning rather than claiming a universal record-system integration layer. A standalone reference experience can be valuable because it is available across different working environments and is not tied to adopting a particular documentation platform.
That independence does not make integration irrelevant or guarantee better answers. It creates a different trade-off: less automatic patient context, but a direct relationship with the clinician and a clear separation between evidence lookup and recording the encounter. Sensitive information still needs appropriate handling in any tool.
The distribution contest will not be settled by counting integrations alone. The winners will make important tasks easier while keeping data movement, responsibilities and exit arrangements understandable. Clinicians should expect connectivity to earn its place through dependable work, not through the visual density of a partner-logo page.
Frequently asked questions
Does Tandem's integration count show how many clinicians actively use it?
No. The number of supported or connected systems describes potential technical reach. Active use, sustained adoption and paid deployment require different evidence.
Is the Aurora teleQ integration available throughout the NHS?
The September 2026 announcement described availability for Swedish healthcare providers using Aurora teleQ. That announcement does not establish NHS-wide or universal international availability.
Should a standalone clinical reference tool be rejected because it is not integrated?
Not automatically. Integration is valuable for some tasks, while portability and an independent reference experience may matter for others. The decision should follow the intended workflow and information-governance requirements.
Keep access to clinical evidence flexible
Use Ask-iatroX as a dedicated reference environment when you need source-linked clinical information alongside the systems used in your workplace.